FluoGuide A/S (STO:FLUO)
30.50
0.00 (0.00%)
Nov 2, 2026, 3:47 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 498.65 million as of November 2, 2026. It is the 29,925th most valuable company in the world and the 394th biggest in Sweden. Its market cap has decreased by 9.60% in one year.
Market Cap
498.65M
Enterprise Value
465.59M
Revenue
404.33K
Global Rank
Country Rank
#394 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 498.65M, an increase of 1,145.93%. That is a compound annual growth rate of 40.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 498.65M | -11.08% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AlzeCure Pharma AB | 882.54M |
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 559.52M |
| Cantargia AB | 451.68M |
| Isofol Medical AB | 383.95M |
| Sprint Bioscience AB | 379.86M |
| Corline Biomedical AB | 371.09M |
| BioInvent International AB | 357.32M |